GLP-1 Receptor Agonists May Reduce Metastatic Progression in Certain Obesity-Related Cancers – The ASCO Post

Canada
  1. GLP-1 Receptor Agonists May Reduce Metastatic Progression in Certain Obesity-Related Cancers  The ASCO Post
  2. Should everyone be on GLP-1s? What the science really tells us about cancer prevention and other benefits  CBC
  3. GLP-1s May Lower The Risk Of These 13 Cancers, New Study Finds  MindBodyGreen
  4. GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk  Medical News Today

Leave a Comment

Your email address will not be published. Required fields are marked *